- Display 15 Products per page
Telehealth and Patient Monitoring Market
Published: August 24, 2017 | Price: $3,995.00 – $6,396.00
Telehealth and Patient Monitoring Market Telehealth is a significant trend as providers struggle to move to a more wireless and streamline operation both within major health facilities and in home treatment markets. What is the market opportunity in telehealth? What companies are succeeding? What disease areas will monitoring be most useful for? How will reimbursement and regulatory trends affect revenues? This Kalorama Information report, representing the tenth report on this subject that Kalorama has published, answers these questions and more,...
European Medical Device Markets (Germany, France, United Kingdom, Italy, Spain, Switzerland, Sweden, Poland, Other Markets)
Published: January 2, 2018 | Price: $3,995.00 – $7,990.00
European Medical Device MarketsEuropean Medical Device Markets provides market size estimate and forecast to 2022 for the European market and individual country revenues, including Germany, France, UK, Italy, Spain, Sweden, Switzerland, and others; an examination of bellwether device companies; revenues for specific categories of medical devices; a look at market drivers and limiters; and competitive analysis of major device manufacturers.The report looks at the European device market and its trends, including medical device spending as a percentage of European health...
Global Over-the-Counter (OTC) Drug Markets
Published: January 23, 2018 | Price: $3,995.00 – $7,990.00
Global Over-the-Counter (OTC) Drug Markets Global Over-the-Counter (OTC) Drug Markets discusses the world and regional OTC markets, including information on the following: world OTC drug market revenues: 2017 to 2023; top twenty OTC drug markets, country market share (%), 2017 (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia, rest of world); and world OTC drug market revenues, markets by product segment, 2017 to 2023...
The Market and Potential for Molecular Point of Care Diagnostic Tests
Published: January 25, 2018 | Price: $3,995.00 – $7,900.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Among the various technologies and products of the global in vitro diagnostics (IVD) market, molecular diagnostics performed at the point of care or near the patient are regarded as a leading expansion market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics,...
The Market and Potential for CRISPR/Cas9 Gene Editing
Published: February 5, 2018 | Price: $3,995.00 – $8,400.00
The Market and Potential for CRISPR/Cas9 Gene Editing This report consolidates the information and trends and provides reliable market estimates for CRISPR technology to 2023. As part of the report's coverage, it provides the following: Market Size and Forecast for CRISPR/Cas9 Gene Editing, 2017-2023 The Market for CRISPR/Cas9 by Region (N. Amer. EU, ROW), 2017-2023 Analysis of Growth Trend by Region Market by Application (Cancer Research, Non-Cancer Disease Research, Cancer Diagnostics, Infection Diagnostics, Plant, Food, Biofuel, Drug Discovery, Drug Development,...
The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
Published: February 16, 2018 | Price: $3,995.00 – $7,990.00
What is the Size of the Point of Care Diagnostic Testing Market? This report provides an in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will...
PCR Markets for Life Sciences Applications (Market by Type – qPCR, dPCR – Application – Pharmaceutical, General Research, and by Country and Region)
Published: March 2, 2018 | Price: $3,995.00 – $7,990.00
PCR Markets for Life Sciences Applications (Market by Type - qPCR, dPCR - Application - Pharmaceutical, General Research, and by Country and Region) As part of its coverage of this market, Kalorama Information's report provides: The Market for Life Sciences PCR, 2017 to 2022 Application Market Segmentation of Pharmaceutical and General Medical Research Market Segmentation of qPCR and dPCR markets, 2017-2022 United States Life Sciences PCR Market, 2017-2022 European Life Sciences PCR Market, 2017-2022 Japanese Market for Life Sciences PCR,...
The Market for In Vitro Diagnostic Test Contract Manufacturing (OEM)
Published: March 30, 2018 | Price: $3,995.00 – $7,990.00
What is The Market for Outsourced Manufacturing of IVD Products? Valued at more than $12 billion in 2017, the global OEM in vitro diagnostic (IVD) manufacturing segment is well positioned for long-term growth. Several trends and factors will boost the revenue potential of this business. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to expand product lines, broaden manufacturing capacity and capabilities, and serve selected customers. Contract IVD...
IVD in China
Published: April 12, 2018 | Price: $3,995.00 – $7,990.00
IVD in China As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang,...
EMR 2018: The Market for Electronic Medical Records (Physician and Hospital EHR Market, Geographic Regions, Trends and Issues)
Published: May 7, 2018 | Price: $3,995.00 – $7,990.00
EMR 2018: The Market for Electronic Medical RecordsEMR 2018, now in its Eleventh Edition, provides a trusted source of analysis of the electronic medical records (EMR) industry. The report looks at the market and trends affecting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics, life expectancy, and company strategies. This 403-page report is a complete global analysis of the EMR / EHR market. A market summary includes a total market analysis,...
Prenatal and Newborn Genetic Screening and Testing Markets (by Application [Carrier Testing, Prenatal Screening, Newborn Testing, Newborn Screening], by Type [Services, Kits] by Geographic Region)
Published: June 5, 2018 | Price: $3,995.00 – $7,990.00
The prenatal and newborn genetic screening and diagnostic testing market has already become a significant market, and it continues to grow – driven by several major factors. The number of genetic tests continues to grow. While many discoveries have been made about the causes of genetic disorders, there remains much more to learn before many of these discoveries can be used as clinical tests – but progress is also being made on this front. While potential causes of inherited disorders...
The IVD Market in the Middle East
Published: July 5, 2018 | Price: $3,995.00 – $7,990.00
The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. The countries covered are: Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE) Other Mideast The Middle East market for in vitro diagnostics is provided in U.S....
The Market and Potential for Molecular Point of Care Diagnostic Tests 2019
Published: February 22, 2019 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Molecular diagnostics performed at the point of care or near the patient is regarded as a leading expansion segment in the global in vitro diagnostics (IVD) market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the...
Out-of-Pocket Healthcare Expenditures in the United States
Published: April 2, 2019 | Price: $4,000.00 – $8,000.00
A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type, by...
The World Molecular Diagnostics Market, 8th Edition
Published: June 6, 2019 | Price: $4,000.00 – $8,000.00
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...